Kenvue KVUE · USD
Consumer Staples · Personal Care Products · US listing · 🇺🇸 United States
S&P 500
19.31
-1.28%
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $37.08bn
- Last close × shares
- Volume
- 66.6m
- Shares, 30 Oct 2026
- Price to earnings
- 25.2
- Dividend yield
- 4.31%
About Kenvue
From its filings with the US Securities and Exchange Commission
Kenvue is based in Summit, New Jersey and is incorporated in Delaware. Its shares trade on NYSE under the ticker KVUE. It is a member of the S&P 500. The SEC classifies its business as perfumes, cosmetics & other toilet preparations. In the fiscal year to 28 December 2025, it reported revenue of $15.12bn and net income of $1.47bn. At that date it held total assets of $27.08bn and shareholders' equity of $10.77bn.
At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day. Built on more than a century of heritage and trusted by generations, our differentiated portfolio of iconic brands—including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, Nicorette®, Tylenol®, and Zyrtec®—is backed by science and recommended by healthcare professionals, which further reinforces our consumers’ connections to our brands.
Our portfolio includes Self Care, Skin Health and Beauty, and Essential Health products, allowing us to connect with consumers across North America, Asia Pacific (“APAC”), Europe, Middle East, and Africa (“EMEA”), and Latin America (“LATAM”) in their daily rituals and the moments that matter most. Our products are marketed across more than 165 countries worldwide.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Latest on Kenvue
Our reporting
- Kenvue rises 4.44% in Thursday's session
- Kenvue rises 2.17% in Tuesday's session
- Kenvue rises 3.61% in Thursday's session
- EU approves Kimberly-Clark's $40 billion Kenvue acquisition
- Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal
- Exclusive-Kimberly-Clark prepares asset sales to win EU nod for Kenvue deal, sources say
Next results
Due on 11 Nov 2026. Analysts expect earnings of 0.30 a share.
Other Consumer Staples listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Kenvue's ticker?
Kenvue trades as KVUE on its US listing, under ISIN US49177J1025.
What was Kenvue's last closing price?
19.31 on 30 Oct 2026. The figure is in USD and is never converted.
When does Kenvue next report results?
Results are expected on 11 Nov 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.